HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network.
Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V, Vias M, Shaw GL, Sharma NL, Ross-Adams H, Scott HE, Vowler SL, Howat WJ, Warren AY, Wooster RF, Mills IG, Neal DE.
Ramos-Montoya A, et al. Among authors: mills ig.
EMBO Mol Med. 2014 May;6(5):651-61. doi: 10.1002/emmm.201303581.
EMBO Mol Med. 2014.
PMID: 24737870
Free PMC article.